National Institutes of Health (NIH) - Bladder Cancer Section, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Biostatistics and Data Management Section, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Laboratory of Translational Genomics, Government of the United States of America - Center for Cancer Research, National Institutes of Health (NIH) - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Clinical Center, Government of the United States of America - Clinical Center, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - Division of Cancer Prevention, National Institutes of Health (NIH) - Clinical Immunotherapy Section, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, City of Hope - Comprehensive Cancer Center, University of Southern California, Columbia University - Herbert Irving Comprehensive Cancer Center, University of California, Davis - Comprehensive Cancer Center, Government of the United States of America - Center for Cancer Research and Ohio State University (OSU) - Department of Internal Medicine

National Institutes of Health (NIH) - Translational Nanobiology Section, National Institutes of Health (NIH) - Translational Nanobiology Section, National Institutes of Health (NIH) - Translational Nanobiology Section, National Institutes of Health (NIH) - Translational Nanobiology Section, National Institutes of Health (NIH) - Translational Nanobiology Section, National Institutes of Health (NIH) - Translational Nanobiology Section, National Institutes of Health (NIH) - Clinical Immunotherapy Section, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health (NIH) - Vaccine Branch, National Institutes of Health (NIH) - Viral Immunology Section, National Institutes of Health (NIH) - Viral Immunology Section, Karolinska Institutet - Clinical Research Center, University Medical Center Hamburg-Eppendorf - Department of Neurosurgery, University Medical Center Hamburg-Eppendorf - Department of Neurosurgery, University Medical Center Hamburg-Eppendorf - Department of Neurosurgery, National Institutes of Health (NIH) - Laboratory of Pathology, National Institutes of Health, National Cancer Institute - Urologic Oncology Branch, Government of the United States of America - Gastrointestinal and Thoracic Malignancy Section, Ben-Gurion University of the Negev - The Shraga Segal Department of Microbiology, Immunology and Genetics, National Institutes of Health (NIH) - Laboratory of Human Carcinogenesis, National Institutes of Health (NIH) - Bladder Cancer Section, Tulane University - Department of Urology, Northeastern University - Barnett Institute of Chemical and Biological Analysis, National Institutes of Health - Developmental Therapeutics Branch, Baylor College of Medicine - Department of Molecular and Human Genetics, PSL Research University - Institut Curie Centre de Recherche, Baylor College of Medicine - Department of Molecular and Human Genetics, PSL Research University - Institut Curie Centre de Recherche, National Institutes of Health (NIH) - Comparative Oncology Program, National Institutes of Health (NIH) - Vaccine Branch, National Institutes of Health - Cancer Data Science Laboratory, National Cancer Institute - Laboratory of Pathology, National Institutes of Health (NIH) - Radiation Oncology Branch, National Institutes of Health (NIH) - Clinical Immunotherapy Section, Harvard Medical School - Department of Medicine, National Institutes of Health (NIH) - Viral Immunology Section and National Institutes of Health (NIH) - Translational Nanobiology Section

National Institutes of Health - Urologic Oncology Branch, National Institutes of Health - Urologic Oncology Branch, National Institutes of Health - Radiation Biology Branch, National Institutes of Health - Urologic Oncology Branch, National Institutes of Health - Radiation Biology Branch, National Institutes of Health - Radiation Biology Branch, National Institutes of Health - Chemical Genomics Center, National Institutes of Health - Chemical Genomics Center, University of Alabama at Birmingham - Mitochondrial Medicine Laboratory, University of Alabama at Birmingham - Mitochondrial Medicine Laboratory, University of Alabama at Birmingham - Mitochondrial Medicine Laboratory, National Institutes of Health - Urologic Oncology Branch, National Institutes of Health - Urologic Oncology Branch, University of Geneva - Department of Cell Biology, National Institutes of Health - Chemical Genomics Center, National Institutes of Health - Chemical Genomics Center, National Institutes of Health - Urologic Oncology Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Chemical Genomics Center, National Institutes of Health - Chemical Genomics Center, University of New Mexico - Health Sciences Center, University of New Mexico - Health Sciences Center, University of New Mexico - Health Sciences Center, National Institutes of Health - Chemical Genomics Center, University of Geneva - Department of Cell Biology, National Institutes of Health - Developmental Therapeutics Branch, National Institutes of Health - Radiation Biology Branch, Government of the United States of America - Leidos Biomedical, Government of the United States of America - Leidos Biomedical, National Institutes of Health - Chemical Genomics Center, University of New Mexico - Health Sciences Center, University of New Mexico - Health Sciences Center, National Institutes of Health - Chemical Genomics Center, Ludwig Institute for Cancer Research, Vanderbilt University - Department of Chemistry, National Institutes of Health - Chemical Genomics Center, University of Alabama at Birmingham - Mitochondrial Medicine Laboratory, National Institutes of Health - Radiation Biology Branch and National Institutes of Health - Urologic Oncology Branch